These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 31306510

  • 21. Inhibition of Prion Propagation by 3,4-Dimethoxycinnamic Acid.
    Zanyatkin I, Stroylova Y, Tishina S, Stroylov V, Melnikova A, Haertle T, Muronetz V.
    Phytother Res; 2017 Jul; 31(7):1046-1055. PubMed ID: 28509424
    [Abstract] [Full Text] [Related]

  • 22. α-Synuclein-Confocal Nanoscanning (ASYN-CONA), a Bead-Based Assay for Detecting Early-Stage α-Synuclein Aggregation.
    Pérez-Pi I, Evans DA, Horrocks MH, Pham NT, Dolt KS, Koszela J, Kunath T, Auer M.
    Anal Chem; 2019 May 07; 91(9):5582-5590. PubMed ID: 30964656
    [Abstract] [Full Text] [Related]

  • 23. Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation.
    Hayden EY, Kaur P, Williams TL, Matsui H, Yeh SR, Rousseau DL.
    Biochemistry; 2015 Aug 04; 54(30):4599-610. PubMed ID: 26161848
    [Abstract] [Full Text] [Related]

  • 24. Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity.
    Lam HT, Graber MC, Gentry KA, Bieschke J.
    Biochemistry; 2016 Feb 02; 55(4):675-85. PubMed ID: 26799377
    [Abstract] [Full Text] [Related]

  • 25. Differential effects of Cu2+ and Fe3+ ions on in vitro amyloid formation of biologically-relevant α-synuclein variants.
    Lorentzon E, Kumar R, Horvath I, Wittung-Stafshede P.
    Biometals; 2020 Jun 02; 33(2-3):97-106. PubMed ID: 32170541
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B, Underwood R, Kamath A, Britain C, McFerrin MB, McLean PJ, Volpicelli-Daley LA, Whitaker RH, Placzek WJ, Becker K, Ma J, Yacoubian TA.
    J Neurosci; 2018 Sep 19; 38(38):8211-8232. PubMed ID: 30093536
    [Abstract] [Full Text] [Related]

  • 28. Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In Vivo.
    Thom T, Schmitz M, Fischer AL, Correia A, Correia S, Llorens F, Pique AV, Möbius W, Domingues R, Zafar S, Stoops E, Silva CJ, Fischer A, Outeiro TF, Zerr I.
    Mov Disord; 2022 Jan 19; 37(1):39-51. PubMed ID: 34448510
    [Abstract] [Full Text] [Related]

  • 29. Phenolic compounds prevent the oligomerization of α-synuclein and reduce synaptic toxicity.
    Takahashi R, Ono K, Takamura Y, Mizuguchi M, Ikeda T, Nishijo H, Yamada M.
    J Neurochem; 2015 Sep 19; 134(5):943-55. PubMed ID: 26016728
    [Abstract] [Full Text] [Related]

  • 30. Effect of Ionic Strength on Thioflavin-T Affinity to Amyloid Fibrils and Its Fluorescence Intensity.
    Mikalauskaite K, Ziaunys M, Sneideris T, Smirnovas V.
    Int J Mol Sci; 2020 Nov 24; 21(23):. PubMed ID: 33255444
    [Abstract] [Full Text] [Related]

  • 31. Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases.
    Longhena F, Spano P, Bellucci A.
    Handb Exp Pharmacol; 2018 Nov 24; 245():85-110. PubMed ID: 28965171
    [Abstract] [Full Text] [Related]

  • 32. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
    Chaari A, Eliezer D, Ladjimi M.
    Int J Biol Macromol; 2016 Feb 24; 83():433-41. PubMed ID: 26601760
    [Abstract] [Full Text] [Related]

  • 33. Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein.
    Albus A, Gold M, Bach JP, Burg-Roderfeld M, Jördens M, Kirchhein Y, Kronimus Y, Mengel D, Zerr I, Dodel R.
    PLoS One; 2018 Feb 24; 13(8):e0202954. PubMed ID: 30157279
    [Abstract] [Full Text] [Related]

  • 34. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
    Glaves JP, Ladner-Keay CL, Bjorndahl TC, Wishart DS, Sykes BD.
    Biochim Biophys Acta Proteins Proteom; 2018 Sep 24; 1866(9):982-988. PubMed ID: 29935976
    [Abstract] [Full Text] [Related]

  • 35. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
    Conway KA, Harper JD, Lansbury PT.
    Biochemistry; 2000 Mar 14; 39(10):2552-63. PubMed ID: 10704204
    [Abstract] [Full Text] [Related]

  • 36. SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway.
    Giehm L, Oliveira CL, Christiansen G, Pedersen JS, Otzen DE.
    J Mol Biol; 2010 Aug 06; 401(1):115-33. PubMed ID: 20540950
    [Abstract] [Full Text] [Related]

  • 37. Single-Molecule Characterization of the Interactions between Extracellular Chaperones and Toxic α-Synuclein Oligomers.
    Whiten DR, Cox D, Horrocks MH, Taylor CG, De S, Flagmeier P, Tosatto L, Kumita JR, Ecroyd H, Dobson CM, Klenerman D, Wilson MR.
    Cell Rep; 2018 Jun 19; 23(12):3492-3500. PubMed ID: 29924993
    [Abstract] [Full Text] [Related]

  • 38. A Capped Peptide of the Aggregation Prone NAC 71-82 Amino Acid Stretch of α-Synuclein Folds into Soluble β-Sheet Oligomers at Low and Elevated Peptide Concentrations.
    Näsström T, Ådén J, Shibata F, Andersson PO, Karlsson BCG.
    Int J Mol Sci; 2020 Feb 27; 21(5):. PubMed ID: 32120928
    [Abstract] [Full Text] [Related]

  • 39. Comparison of α-Synuclein Fibril Inhibition by Four Different Amyloid Inhibitors.
    Jha NN, Kumar R, Panigrahi R, Navalkar A, Ghosh D, Sahay S, Mondal M, Kumar A, Maji SK.
    ACS Chem Neurosci; 2017 Dec 20; 8(12):2722-2733. PubMed ID: 28872299
    [Abstract] [Full Text] [Related]

  • 40. α-Synuclein aggregation at low concentrations.
    Afitska K, Fucikova A, Shvadchak VV, Yushchenko DA.
    Biochim Biophys Acta Proteins Proteom; 2019 Dec 20; 1867(7-8):701-709. PubMed ID: 31096048
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.